| Vitamin B12 is an essential nutrient that the body relies on for growth, energy, and healthy brain function. What many people don’t realize is that, unlike most nutrients, B12 is used in only two biochemical reactions, yet both are so important that even small disruptions can cause widespread symptoms. One of these enzymes, methionine synthase, helps drive DNA synthesis, red blood cell formation, and the methylation processes that influence mood, behavior, and detoxification. |
Understanding these signs is important, but to truly address B12 deficiency, we also need to understand why it happens. The cause is rarely just low intake. More often, something has gone wrong along B12’s complicated journey through the digestive system, bloodstream, or even entry into the brain. To see how these problems develop, let’s follow B12’s path from start to finish.
When you eat meat, fish, or dairy, vitamin B12 is bound tightly to proteins. In the stomach, strong gastric acid and the enzyme pepsin must first free it. At the same time, the stomach’s parietal cells produce intrinsic factor (IF), a special protein that will later help B12 survive digestion and be absorbed. Low stomach acid (often caused by proton pump inhibitors, H. pylori infection, or atrophic gastritis) is one of the most common reasons for poor B12 absorption. If this first step fails, the rest of the process can’t happen.
After leaving the stomach, B12 is temporarily protected by another protein called haptocorrin, produced in saliva and stomach lining. In the duodenum, pancreatic enzymes break down this complex so B12 can attach to intrinsic factor instead. This B12–IF pair travels through the small intestine until it reaches the terminal ileum, where highly specific receptors (the cubilin–amnionless–megalin complex) absorb it into the intestinal cells. This step requires adequate calcium, so calcium deficiency or certain medications like metformin can interfere here too.
Once inside the intestinal cells, B12 is transferred to transcobalamin II (TCII), forming a biologically active complex known as holo-TCII. This complex is released into the bloodstream and carries B12 to tissues throughout the body. Only about 20% of circulating B12 exists in this active, available form; the rest is bound to proteins that don’t deliver it to cells.
To actually use B12, each cell must take up holo-TCII through a receptor called TCblR (CD320). Once inside, B12 undergoes several enzymatic conversions to become either:
- Methylcobalamin, used in the cytosol for methylation and neurotransmitter synthesis, or
- Adenosylcobalamin, used in mitochondria for energy metabolism.
B12 also reaches the brain through the choroid plexus, where nutrients are transported into the cerebrospinal fluid (CSF). Folate and vitamin B12 have a closely linked, co-dependent relationship because both nutrients must be present in adequate amounts for proper conversion into their active forms that support essential metabolic reactions. When folate receptor autoantibodies (FRAA) are present, folate transport into the brain may be impaired, and this disruption can indirectly affect B12-dependent processes as well. This is an important consideration in children with developmental or neurological conditions. Notably, children who test positive for FRAA have been shown to exhibit elevated serum B12, which may reflect inefficient cellular or CNS utilization of B12 rather than true sufficiency. (Frye et al., 2016)
Even with good cellular levels, the brain poses another obstacle. The blood–brain barrier (BBB) allows only specific forms of B12, still attached to transcobalamin II, to pass through. This process depends on the CD320 receptor found on the brain’s capillary cells. Inflammation, oxidative stress, and low active B12 (holo-TCII) in the blood can all reduce brain delivery, which is why neurological symptoms can occur even when a blood test looks “normal.”
Recently, researchers identified auto-antibodies against the CD320 receptor, which is required for B12 transport into cells and across the blood–brain barrier. These antibodies blocked B12 uptake and resulted in low cerebrospinal fluid B12 despite normal serum levels. This discovery is very new, and more research is needed to understand whether these antibodies may also play a role in children with neurodevelopmental conditions. (Pluvinage et al., 2024)
Once in the CSF, B12 enters neurons and glial cells through the same CD320 receptor system. There, it supports the methylation of DNA, synthesis of neurotransmitters like dopamine and serotonin, and maintenance of the myelin sheath that insulates nerve fibers. Every one of these processes relies on a steady supply of active B12.
This complex journey explains why some people show signs of B12 deficiency even with “normal” serum levels. The issue may not be intake, but transport, conversion, or delivery to the brain. Children with neurological or developmental concerns, gastrointestinal disorders, or autoimmune issues may have multiple barriers affecting absorption and utilization.
Certain supplement forms can skip some of these steps:
- Sublingual or intranasal B12 bypasses the stomach and intestine.
- B12 injections deliver it directly into circulation, avoiding all digestive barriers.
- Methylcobalamin and adenosylcobalamin forms provide active coenzymes that cells can use immediately.
Low-dose Lithium has been proposed to enhance cellular uptake of both folate and vitamin B12, potentially by improving transport mechanisms into cells and the brain.
(Mischley et al., 2014; Marshall, 2015; Szklarska et al., 2019). Although some clinical data are conflicting, cell-line and hair-analysis studies suggest lithium may support B12 and folate transport, so in complex cases of nutrient delivery dysfunction, considering lithium’s role may offer an adjunctive strategy. (Schrauzer et al., 1992)
To accurately evaluate vitamin B12 levels and function in the body, it’s important to look beyond a simple serum B12 level. A comprehensive assessment includes:
- Serum Vitamin B12
Measures total circulating B12, but can appear normal or elevated even when B12 is not being used efficiently at the cellular level. - Methylmalonic Acid (MMA)
The most sensitive indicator of intracellular B12 activity; MMA increases when B12 is not adequately available inside cells, even if serum B12 looks normal. - Mean Corpuscular Volume (MCV)
Helps identify enlarged red blood cells, a classic sign of B12 or folate deficiency, even when serum levels appear normal. - Homocysteine
Elevated levels suggest impaired methylation' often due to low B12, low folate, or low B6. Useful for identifying functional deficiency. - Holo-Transcobalamin (Active B12)
Measures the fraction of B12 actually bound to transcobalamin II and available for cellular uptake. Low levels can occur despite normal or high serum B12. - Intrinsic Factor (IF) Antibodies
Detects autoimmune interference with B12 absorption. Positive results may indicate pernicious anemia or impaired binding of B12 to intrinsic factor. - Parietal Cell Antibodies
Screens for autoimmune gastritis, which reduces intrinsic factor and stomach acid production - both essential for proper B12 absorption. - Serum Gastrin
Elevated levels suggest low stomach acid (hypochlorhydria), a common cause of poor B12 release from food proteins. - Folate Receptor Alpha Antibodies (FRAA)
Useful when neurological symptoms or developmental concerns are present. FRAA can impair folate delivery to the brain and indirectly disrupt B12-dependent pathways. - Transcobalamin Receptor (CD320) Antibodies – emerging research
Commercial testing is not yet available, but may become accessible as research advances.
Understanding how vitamin B12 is absorbed, transported, and delivered to the brain allows us to identify where barriers may be occurring and how to support each step more effectively. Because every child’s physiology is unique, a thoughtful assessment, paired with clinically guided supplementation, can make a meaningful difference in energy, cognition, behavior, and overall development. As research continues to uncover new insights into nutrient transport and brain access, we have more tools than ever to individualize care and help children reach their fullest potential.
- Frye, R. E., Delhey, L., Slattery, J., Tippett, M., Wynne, R., Rose, S., Kahler, S. G., Bennuri, S. C., Melnyk, S., Sequeira, J. M., & Quadros, E. V. (2016). Blocking and binding folate receptor-α autoantibodies identify novel autism spectrum disorder subgroups. Frontiers in Neuroscience, 10, 80.
- Graham, R. M., Ziegler, H. L., Puri, P. K., Nhiwatiwa, L., & Quadros, E. V. (2024). Autoantibodies to the transcobalamin receptor inhibit B12 transport into the brain. Nutrients, 16(14), 2392.
- Marshall, T. M. (2015). Lithium as a nutrient. Journal of American Physicians and Surgeons, 20(4), 104–109.
- Mischley, L. K., Weaver, K. E., & Herald, J. (2014). Nutritional and botanical approaches to neurology: A review of the evidence. Journal of the American College of Nutrition, 33(3), 210–223.
- Schrauzer, G. N., Shrestha, K. P., & Flores-Arce, M. F. (1992). Lithium in scalp hair of adults, students, and violent criminals: Effects of supplementation and evidence for interactions with vitamin B12 and with other trace elements. Biological Trace Element Research, 34, 161–176.
- Szklarska, D., & Rzymski, P. (2019). Is lithium a micronutrient? From biological activity and epidemiological observation to food fortification. Biological Trace Element Research, 189(1), 18–27.
RSS Feed